Form 8-K - Current report:
SEC Accession No. 0000950170-22-026329
Filing Date
2022-12-12
Accepted
2022-12-12 06:03:01
Documents
17
Period of Report
2022-12-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20221210.htm   iXBRL 8-K 78303
2 EX-99.1 acet-ex99_1.htm EX-99.1 132693
3 GRAPHIC img94724212_0.jpg GRAPHIC 2037
4 GRAPHIC img94724212_1.jpg GRAPHIC 95546
5 GRAPHIC img103908346_0.jpg GRAPHIC 67792
6 GRAPHIC img103908346_1.jpg GRAPHIC 58860
  Complete submission text file 0000950170-22-026329.txt   797812

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20221210_pre.xml EX-101.PRE 10289
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20221210.xsd EX-101.SCH 2472
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20221210_lab.xml EX-101.LAB 14018
11 EXTRACTED XBRL INSTANCE DOCUMENT acet-20221210_htm.xml XML 4933
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 221456062
SIC: 2834 Pharmaceutical Preparations